Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

LEO 29102 Single and Multiple Dose Study by Dermal Application

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
LEO Pharma
ClinicalTrials.gov Identifier:
NCT00891709
First received: April 30, 2009
Last updated: March 2, 2016
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)